SPHINGOTEC GROUP
COMBINING INNOVATIVE BIOMARKERS WITH OUTSTANDING TECHNOLOGY
LATEST NEWS
Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression. sphingotec launches first IVD test for DPP3 on Nexus IB10 Point-of-Care platform
Sphingotec reveals novel results on bioactive adrenomedullin for diagnosis and therapy monitoring of septic shock at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
Sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology
Endothelial disruption: Rapid translation from bench to bedside